找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Adjuvant Therapy of Primary Breast Cancer; Hans-J?rg Senn,Aron Goldhirsch,Bruno Osterwalder Conference proceedings 1989 Springer-Verlag Be

[復(fù)制鏈接]
樓主: 你太謙虛
31#
發(fā)表于 2025-3-26 23:32:57 | 只看該作者
Dirichlet and Polya tree process,subsequent course (Kurtz et al. 1988 a). The purpose of this paper is to analyze the development of breast recurrence as a function of time, as well as to study the prognosis following treatment of local failure.
32#
發(fā)表于 2025-3-27 04:28:44 | 只看該作者
Inference for Location Parameter,n of patients whose tumors are more responsive to a given treatment (e.g. patients with estrogen-receptor(ER)-positive tumors, who are receiving adjuvant endocrine therapy) (Ludwig Breast Cancer Study Group 1984). The use of sequential non-cross-resistant combinations also appears to enhance effectiveness (Perloff et al. 1986).
33#
發(fā)表于 2025-3-27 09:01:44 | 只看該作者
34#
發(fā)表于 2025-3-27 11:09:33 | 只看該作者
35#
發(fā)表于 2025-3-27 17:21:17 | 只看該作者
36#
發(fā)表于 2025-3-27 20:03:46 | 只看該作者
Dirichlet and Polya tree process,reasing doses through a multilog cell kill model. In this regard, the alkylating agents more closely resemble radiotherapy. The lack of cross-resistance among the alkylating agents in both in vitro and in vivo models has important implications for clinical treatment strategies (Frei et al. 1985; Frei et al., in press; Teicher et al. 1986).
37#
發(fā)表于 2025-3-28 00:18:58 | 只看該作者
38#
發(fā)表于 2025-3-28 02:41:26 | 只看該作者
0080-0015 in this disease, the benefits of therapy are relatively mod- est, the availability and interpretation of the data from trials be- comes an issue of primary importance. The effects of present treat- ment are in fact such that more patients relapse despite therapy than are estimated to benefit from i
39#
發(fā)表于 2025-3-28 08:30:31 | 只看該作者
40#
發(fā)表于 2025-3-28 11:14:12 | 只看該作者
Inference for Location Parameter,research. There is no question that such a development, if proven correct, will result in very significant practical alterations of the orthodox management of breast cancer. Therefore, before its full implementation, rigorous testing in clinical trials will be required.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 14:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
渭源县| 宁强县| 吉木乃县| 锡林郭勒盟| 吉安县| 陆良县| 太谷县| 湘西| 黑水县| 福泉市| 阳泉市| 道真| 龙州县| 侯马市| 图木舒克市| 苏尼特左旗| 英德市| 沙河市| 深圳市| 都安| 荥阳市| 成武县| 灵寿县| 获嘉县| 吉林省| 呼玛县| 丹棱县| 巍山| 苏尼特右旗| 高要市| 新营市| 龙泉市| 玉门市| 平谷区| 临安市| 大余县| 佳木斯市| 牡丹江市| 西乌珠穆沁旗| 瑞安市| 甘孜|